StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-2.91%)

Close on Nov 17, 2026Market cap $383.64KP/E –Yield –

VivoSim Labs ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

VivoSim Labs's ebitda for the twelve months ending Jun 30, 2026 was -$11.14M. For fiscal 2026 it was -$11.27M. The highest annual figure on record is -$1.12M in fiscal 2010.

Annual ebitda

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$11.27M–
FY2025Mar 31, 2025-$12.35M–
FY2024Mar 31, 2024-$14.81M–
FY2023Mar 31, 2023-$17.44M–
FY2022Mar 31, 2022-$11.34M–
FY2021Mar 31, 2021-$16.79M–
FY2020Mar 31, 2020-$20.33M–
FY2019Mar 31, 2019-$26.29M–
FY2018Mar 31, 2018-$34.00M–
FY2017Mar 31, 2017-$37.43M–
FY2016Mar 31, 2016-$37.83M–
FY2015Mar 31, 2015-$29.83M–
FY2012Dec 31, 2012-$9.12M–
FY2011Dec 31, 2011-$2.24M–
FY2010Dec 31, 2010-$1.12M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$2.72M–
Q4 FY2026CQ1 2026Mar 31, 2026-$3.14M–
Q3 FY2026CQ4 2025Dec 31, 2025-$2.70M–
Q2 FY2026CQ3 2025Sep 30, 2025-$2.58M–
Q1 FY2026CQ2 2025Jun 30, 2025-$2.85M–
Q4 FY2025CQ1 2025Mar 31, 2025-$3.09M–
Q3 FY2025CQ4 2024Dec 31, 2024-$3.40M–
Q2 FY2025CQ3 2024Sep 30, 2024-$2.54M–
Q1 FY2025CQ2 2024Jun 30, 2024-$3.32M–
Q4 FY2024CQ1 2024Mar 31, 2024-$3.03M–
Q3 FY2024CQ4 2023Dec 31, 2023-$3.61M–
Q2 FY2024CQ3 2023Sep 30, 2023-$4.04M–
Q1 FY2024CQ2 2023Jun 30, 2023-$4.13M–
Q4 FY2023CQ1 2023Mar 31, 2023-$7.72M–
Q3 FY2023CQ4 2022Dec 31, 2022-$3.23M–
Q2 FY2023CQ3 2022Sep 30, 2022-$3.30M–
Q1 FY2023CQ2 2022Jun 30, 2022-$3.19M–
Q4 FY2022CQ1 2022Mar 31, 2022-$1.87M–
Q3 FY2022CQ4 2021Dec 31, 2021-$3.46M–
Q2 FY2022CQ3 2021Sep 30, 2021-$3.47M–
Q1 FY2022CQ2 2021Jun 30, 2021-$2.53M–
Q4 FY2021CQ1 2021Mar 31, 2021-$2.58M–
Q3 FY2021CQ4 2020Dec 31, 2020-$2.48M–
Q2 FY2021CQ3 2020Sep 30, 2020-$8.95M–
Q1 FY2021CQ2 2020Jun 30, 2020-$2.78M–
Q4 FY2020CQ1 2020Mar 31, 2020-$2.89M–
Q3 FY2020CQ4 2019Dec 31, 2019-$4.48M–
Q2 FY2020CQ3 2019Sep 30, 2019-$6.65M–
Q1 FY2020CQ2 2019Jun 30, 2019-$6.32M–
Q4 FY2019CQ1 2019Mar 31, 2019-$7.01M–
Q3 FY2019CQ4 2018Dec 31, 2018-$6.27M–
Q2 FY2019CQ3 2018Sep 30, 2018-$5.73M–
Q1 FY2019CQ2 2018Jun 30, 2018-$7.29M–
Q4 FY2018CQ1 2018Mar 31, 2018-$7.28M–
Q3 FY2018CQ4 2017Dec 31, 2017-$7.59M–
Q2 FY2018CQ3 2017Sep 30, 2017-$9.26M–
Q1 FY2018CQ2 2017Jun 30, 2017-$9.87M–
Q4 FY2017CQ1 2017Mar 31, 2017-$10.36M–
Q3 FY2017CQ4 2016Dec 31, 2016-$9.31M–
Q2 FY2017CQ3 2016Sep 30, 2016-$9.23M–

More VivoSim Labs figures

See a number that looks wrong?